Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Morningstar (MORN) Cash & Equivalents (2016 - 2025)

Morningstar (MORN) has disclosed Cash & Equivalents for 17 consecutive years, with $474.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 5.61% to $474.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $474.5 million, a 5.61% decrease, with the full-year FY2025 number at $474.5 million, down 5.61% from a year prior.
  • Cash & Equivalents was $474.5 million for Q4 2025 at Morningstar, roughly flat from $474.2 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $552.9 million in Q3 2024 to a low of $325.0 million in Q3 2023.
  • A 5-year average of $420.9 million and a median of $389.4 million in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: dropped 27.16% in 2023, then surged 70.12% in 2024.
  • Morningstar's Cash & Equivalents stood at $483.8 million in 2021, then decreased by 22.16% to $376.6 million in 2022, then decreased by 10.28% to $337.9 million in 2023, then surged by 48.77% to $502.7 million in 2024, then dropped by 5.61% to $474.5 million in 2025.
  • Per Business Quant, the three most recent readings for MORN's Cash & Equivalents are $474.5 million (Q4 2025), $474.2 million (Q3 2025), and $503.5 million (Q2 2025).